“This news describes a sector-driven single-day price increase for ARWR with no company-specific catalyst identified. The gain reflects macro or sector sentiment rather than any operational or clinical development at Arrowhead. Evidence is insufficient to draw conclusions about ARWR's business trajectory, pipeline progress, or long-term valuation from this single article. Investors should not interpret this move as indicative of a change in fundamental value.”